Podcast in English
Text size
Bulgarian National Radio © 2025 All Rights Reserved

Bulgaria provides funding for three new medicines used for the treatment of Covid-19

Bulgaria will provide funding for three new medicines used for the treatment of Covid-19. Today, Bulgaria's government adopted a decree which allows this country to buy the following three medicines for the treatment of Covid-19: Molnupiravir, Regkirona and Anakinra.

Molnupiravir is an oral antiviral medicine, for the treatment of mild-to-mederate Covid-19 in adults who are at risk for progressing to severe Covid-19 and/or hospitalization. Regkirona is a medicine used for treating Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of their disease becoming severe. Anakinra is a medicine used for the treatment of coronavirus disease in adult patients with pneumonia who are at risk of developing severe respiratory failure




Последвайте ни и в Google News Showcase, за да научите най-важното от деня!
Listen to the daily news from Bulgaria presented in "Bulgaria Today" podcast, available in Spotify.

More from category

Light precipitation is expected in the southern regions of the country

During the night, the sky will be mostly clear over most of the country. There will be more significant cloudiness over the southern regions and in some places light precipitation is possible. On Friday, it will be mostly..

published on 8/14/25 7:10 PM

Bulgarian services dismantle Spain-to-Turkey drug trafficking ring

An organised criminal group trafficking drugs from Spain and the Netherlands to Turkey has been dismantled by the State Agency for National Security (DANS) and the General Directorate for Combating Organised Crime (GDBOP). The leader of the group and..

published on 8/14/25 5:29 PM

Six European countries help Bulgaria fight fires

Last week, Greece, Spain, Bulgaria, Montenegro and Albania activated the EU Civil Protection Mechanism to help them deal with forest fires, many of which are occurring simultaneously across Europe, the European Commission announced...

published on 8/14/25 4:50 PM